Literature DB >> 20090336

Ulcerative colitis with multidrug-resistant Pseudomonas aeruginosa infection successfully treated with bifidobacterium.

Azusa Nagasaki1, Hirokazu Takahashi, Mizue Iinuma, Takashi Uchiyama, Seitaro Watanabe, Tomoko Koide, Chikako Tokoro, Masahiko Inamori, Yasunobu Abe, Atsushi Nakajima.   

Abstract

A 71-year-old man was diagnosed with ulcerative colitis (UC) complicated by bacterial infections, and his active disease proved difficult to treat with steroid therapy or antibiotics. Although the patient's UC failed to respond to several types of induction therapy, his condition finally improved when treated using Bifidobacterium. Probiotics could be one of the treatment agents for induction of remission in UC. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20090336     DOI: 10.1159/000236042

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  4 in total

1.  Campylobacter jejuni and Pseudomonas coinfection in the setting of ulcerative colitis.

Authors:  John Paul Iguidbashian; Jai D Parekh; Shweta Kukrety; Venkata Giri Andukuri
Journal:  BMJ Case Rep       Date:  2018-06-06

Review 2.  Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients.

Authors:  Daisy Jonkers; John Penders; Ad Masclee; Marieke Pierik
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

3.  In vitro anti-tuberculosis effect of probiotic Lacticaseibacillus rhamnosus PMC203 isolated from vaginal microbiota.

Authors:  Md Abdur Rahim; Hoonhee Seo; Sukyung Kim; Hanieh Tajdozian; Indrajeet Barman; Youngkyoung Lee; Saebim Lee; Ho-Yeon Song
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

4.  Effects of probiotics on Toll‑like receptor expression in ulcerative colitis rats induced by 2,4,6‑trinitro‑benzene sulfonic acid.

Authors:  Ping Yao; Fang Tan; Hongliang Gao; Lei Wang; Tao Yang; Yongbo Cheng
Journal:  Mol Med Rep       Date:  2017-02-21       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.